Michael Barry Kastan
William and Jane Shingleton Distinguished Professor of Pharmacology and Cancer Biology
Current Appointments & Affiliations
- William and Jane Shingleton Distinguished Professor of Pharmacology and Cancer Biology, Pharmacology & Cancer Biology, Basic Science Departments 2012
- Professor of Pharmacology and Cancer Biology, Pharmacology & Cancer Biology, Basic Science Departments 2012
- Director of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2011
- Professor of Pediatrics, Pediatrics, Clinical Science Departments 2012
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2010
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2011
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2017
Contact Information
- DUMC Box 3917, 10 Bryan Searle Drive, Rm 422, Durham, NC 27710
- DUMC Box 3917, 10 Bryan Searle Drive, Rm 422, Durham, NC 27710
-
michael.kastan@duke.edu
(919) 684-3052
- Background
-
Education, Training, & Certifications
- M.D., Washington University in St. Louis 1984
- Ph.D., Washington University in St. Louis 1984
-
Duke Appointment History
- Consulting Professor in Pediatrics, Pediatrics, Hematology-Oncology, Pediatrics 2011 - 2012
- Consulting Professor of Pharmacology and Cancer Biology, Pharmacology & Cancer Biology, Basic Science Departments 2011 - 2012
- Recognition
-
In the News
-
APR 18, 2017 Duke Health News -
APR 4, 2017 Duke Health News -
JUN 29, 2016 WNCN -
MAY 4, 2016 -
MAR 4, 2016 The News & Observer -
FEB 12, 2016 The News & Observer -
FEB 10, 2016 -
JAN 29, 2016 WRAL -
JAN 27, 2016 -
OCT 22, 2015 The New York Times -
MAY 13, 2014 Triangle Business Journal -
MAY 2, 2014 -
APR 23, 2014 -
SEP 30, 2013
-
-
Awards & Honors
- Fellow, American Association for Cancer Research Academy. American Association for Cancer Research. 2017
- Member. National Academy of Sciences. 2016
- Fellow. American Academy of Arts and Sciences . 2014
- Fellow. American Academy of Arts and Sciences. 2014
- Fellow. American Association for the Advancement of Science. 2013
- Member. National Academy of Medicine. 2009
- MERIT Award. National Institutes of Health. 2005
- Member. Association of American Physicians. 2003
- Highly Cited Researcher. Thomson Reuters. 2001
- Member. American Society of Clinical Investigation. 1995
- Research
-
Selected Grants
- Pharmacological Sciences Training Grant awarded by National Institutes of Health 2020 - 2025
- Cancer Center Support Grant awarded by National Institutes of Health 1976 - 2024
- Unified Program for Therapeutics in Children awarded by National Institutes of Health 2019 - 2024
- Duke Resident Physician-Scientist Program in Radiation Oncology and Radiology awarded by National Institutes of Health 2020 - 2024
- Does Loss of ATM Suppression of the SMG1 Kinase Contribute to the A-T Phenotype? 2020 - 2023
- The Role of USP22 in Prostate Cancer Development and Progression awarded by National Institutes of Health 2019 - 2023
- Medical Scientist Training Program awarded by National Institutes of Health 1997 - 2022
- Kastan Gray Foundation Project 2017 - 2021
- Evaluation of kinase inhibitors 2016 - 2021
- The role of ATM in Metabolic Stress Responses awarded by National Institutes of Health 2011 - 2021
- The role of Mtss1 in Hedgehog-mediated intestinal cancer stem cell function awarded by National Institutes of Health 2015 - 2020
- Pharmacological Sciences Training Program awarded by National Institutes of Health 1975 - 2020
- C30 Canine Pilot Research awarded by V Foundation for Cancer Research 2016 - 2020
- Stimulate Research in HIV/AIDS Cancer Research Projects at NCI-designated Cancer Centers awarded by National Institutes of Health 2015 - 2019
- Collaborative Success: Expanding Options for Patients with Melanoma awarded by National Institutes of Health 1997 - 2019
- Duke Cancer Institute Application for Administrative Supplement for the P30 Cancer Center Support Grant to Develop Tobacco Cessation Treatment Capacity and Infrastructure for Cancer Patients awarded by National Institutes of Health 1997 - 2019
- Duke University Program in Environmental Health awarded by National Institute of Environmental Health Sciences 2013 - 2019
- Cellular Stress Response Signaling Pathways awarded by National Institutes of Health 1992 - 2019
- Copy Number Alterations in Low Mutation Cancer awarded by National Institutes of Health 2018 - 2019
- Identification of Therapeutic Interventions in Ataxia-Telangiectasia Using a Novel Model of Metabolic Stress awarded by University of Pennsylvania 2017 - 2018
- Center for Molecular & Cellular Studies of Ped Disease awarded by National Institutes of Health 2003 - 2018
- Using bacterial CRISPR/Cas endonucleases to selectively eliminate HPV-transformed cells in vivo awarded by National Institutes of Health 2015 - 2017
- Development and Validation of Novel Therapeutic Targets in Anal Cancer 2015 - 2016
- Metabolic Sensing and Stress Response Deficit in Ataxia Telangiectasia 2014 - 2016
- Chromatin Modulation Associated with DNA Breakage and Repair in Human Cells awarded by National Institutes of Health 2011 - 2016
- Cancer Biology Training Grant awarded by National Cancer Institute 1993 - 2016
- Evaluating GSK2126458 with radiation therapy in pre-clinical models 2013 - 2015
- Screening for ATM/DNA-PK inhibitors 2014 - 2015
-
External Relationships
- Boston Children's Hospital
- Elsevier
- Scientific Advisory Board of the following Cancer Centers - UPenn, Washington University, Univ Pittsburgh, Univ Michigan, Stanford, UNC-CH, Cornell, USC
- Stand-up-to-Cancer (SU2C) and Jimmy V Foundation
- X-Rad Therapeutics
- Publications & Artistic Works
-
Selected Publications
-
Books
-
Niederhuber, J. E., J. O. Armitage, J. H. Doroshow, M. B. Kastan, and J. E. Tepper. Preface, 2014. https://doi.org/10.1016/B978-1-4557-2865-7.00114-4.Full Text
-
Niederhuber, J. E., J. O. Armitage, J. H. Doroshow, M. B. Kastan, and J. E. Tepper. Abeloff's Clinical Oncology: Fifth Edition, 2013.
-
-
Academic Articles
-
Sze, Sei-Gyung K., Howard M. Lederman, Thomas O. Crawford, Michael F. Wangler, Andrea M. Lewis, Michael B. Kastan, Harpreet K. Dibra, Alexander M. R. Taylor, and Daniel S. Wechsler. “Retrospective Diagnosis of Ataxia-Telangiectasia in an Adolescent Patient With a Remote History of T-Cell Leukemia.” J Pediatr Hematol Oncol, November 14, 2019. https://doi.org/10.1097/MPH.0000000000001672.Full Text Link to Item
-
McGill, Janet B., Mariko Johnson, Stacy Hurst, William T. Cade, Kevin E. Yarasheski, Richard E. Ostlund, Kenneth B. Schechtman, et al. “Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness.” Diabetol Metab Syndr 11 (2019): 61. https://doi.org/10.1186/s13098-019-0456-4.Full Text Link to Item
-
Chen, Jing, and Michael B. Kastan. “A novel DNA damage-induced alternative splicing pathway that regulates p53 and cellular senescence markers.” Oncoscience 4, no. 9–10 (September 2017): 122–23. https://doi.org/10.18632/oncoscience.367.Full Text Open Access Copy Link to Item
-
Chen, Jing, John Crutchley, Dadong Zhang, Kouros Owzar, and Michael B. Kastan. “Identification of a DNA Damage-Induced Alternative Splicing Pathway That Regulates p53 and Cellular Senescence Markers.” Cancer Discov 7, no. 7 (July 2017): 766–81. https://doi.org/10.1158/2159-8290.CD-16-0908.Full Text Link to Item
-
Liu, Xinjian, Fang Li, Qian Huang, Zhengxiang Zhang, Ling Zhou, Yu Deng, Min Zhou, et al. “Self-inflicted DNA double-strand breaks sustain tumorigenicity and stemness of cancer cells.” Cell Res 27, no. 6 (June 2017): 764–83. https://doi.org/10.1038/cr.2017.41.Full Text Link to Item
-
Kastan, Michael B. “Commentary on "Participation of p53 Protein in the Cellular Response to DNA Damage".” Cancer Res 76, no. 13 (July 1, 2016): 3663–65. https://doi.org/10.1158/0008-5472.CAN-16-1560.Full Text Link to Item
-
LeBlanc, Amy K., Matthew Breen, Peter Choyke, Mark Dewhirst, Timothy M. Fan, Daniel L. Gustafson, Lee J. Helman, et al. “Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative Oncology.” Sci Transl Med 8, no. 324 (February 3, 2016): 324ps5. https://doi.org/10.1126/scitranslmed.aaf0746.Full Text Link to Item
-
Min, Jaeki, Kexiao Guo, Praveen K. Suryadevara, Fangyi Zhu, Gloria Holbrook, Yizhe Chen, Clementine Feau, et al. “Optimization of a Novel Series of Ataxia-Telangiectasia Mutated Kinase Inhibitors as Potential Radiosensitizing Agents.” J Med Chem 59, no. 2 (January 28, 2016): 559–77. https://doi.org/10.1021/acs.jmedchem.5b01092.Full Text Link to Item
-
Bakkenist, Christopher J., and Michael B. Kastan. “Chromatin perturbations during the DNA damage response in higher eukaryotes.” Dna Repair (Amst) 36 (December 2015): 8–12. https://doi.org/10.1016/j.dnarep.2015.09.002.Full Text Link to Item
-
Zhang, Jiangwei, Durga Nand Tripathi, Ji Jing, Angela Alexander, Jinhee Kim, Reid T. Powell, Ruhee Dere, et al. “ATM functions at the peroxisome to induce pexophagy in response to ROS.” Nat Cell Biol 17, no. 10 (October 2015): 1259–69. https://doi.org/10.1038/ncb3230.Full Text Link to Item
-
Goldstein, Michael, and Michael B. Kastan. “Repair versus Checkpoint Functions of BRCA1 Are Differentially Regulated by Site of Chromatin Binding.” Cancer Res 75, no. 13 (July 1, 2015): 2699–2707. https://doi.org/10.1158/0008-5472.CAN-15-0400.Full Text Link to Item
-
Zhang, Minsi, Qiong Qiu, Zhizhong Li, Mohit Sachdeva, Hooney Min, Diana M. Cardona, Thomas F. DeLaney, et al. “HIF-1 Alpha Regulates the Response of Primary Sarcomas to Radiation Therapy through a Cell Autonomous Mechanism.” Radiat Res 183, no. 6 (June 2015): 594–609. https://doi.org/10.1667/RR14016.1.Full Text Link to Item
-
Goldstein, Michael, and Michael B. Kastan. “The DNA damage response: implications for tumor responses to radiation and chemotherapy.” Annu Rev Med 66 (2015): 129–43. https://doi.org/10.1146/annurev-med-081313-121208.Full Text Link to Item
-
Henriksson, Sofia, Hanif Rassoolzadeh, Elisabeth Hedström, Christos Coucoravas, Alexander Julner, Michael Goldstein, Gabriela Imreh, et al. “The scaffold protein WRAP53β orchestrates the ubiquitin response critical for DNA double-strand break repair.” Genes Dev 28, no. 24 (December 15, 2014): 2726–38. https://doi.org/10.1101/gad.246546.114.Full Text Link to Item
-
Kastan, Michael B. “Abstract IA08: Ataxia-telangiectasia: Broad implications from the study of a rare disease.” Genetic Predisposition to Pediatric Cancers, October 15, 2014. https://doi.org/10.1158/1538-7445.pedcan-ia08.Full Text
-
Kennedy, Edward M., Anand V. R. Kornepati, Michael Goldstein, Hal P. Bogerd, Brigid C. Poling, Adam W. Whisnant, Michael B. Kastan, and Bryan R. Cullen. “Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.” J Virol 88, no. 20 (October 2014): 11965–72. https://doi.org/10.1128/JVI.01879-14.Full Text Link to Item
-
Wang, Qinhong, Michael Goldstein, Peter Alexander, Timothy P. Wakeman, Tao Sun, Junjie Feng, Zhenkun Lou, Michael B. Kastan, and Xiao-Fan Wang. “Rad17 recruits the MRE11-RAD50-NBS1 complex to regulate the cellular response to DNA double-strand breaks.” Embo J 33, no. 8 (April 16, 2014): 862–77. https://doi.org/10.1002/embj.201386064.Full Text Link to Item
-
Guo, Kexiao, Anang A. Shelat, R Kiplin Guy, and Michael B. Kastan. “Development of a cell-based, high-throughput screening assay for ATM kinase inhibitors.” J Biomol Screen 19, no. 4 (April 2014): 538–46. https://doi.org/10.1177/1087057113520325.Full Text Link to Item
-
Sandlund, J. T., M. M. Hudson, W. Kennedy, M. Onciu, and M. B. Kastan. “Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature B-cell malignancies.” Pediatr Blood Cancer 61, no. 2 (February 2014): 360–62. https://doi.org/10.1002/pbc.24696.Full Text Link to Item
-
Guo, K., A. Anang, R. Shelat, K. Guy, and M. B. Kastan. “Erratum: Development of a cell-based, high-throughput screening assay for atm kinase inhibitors (Journal of Biomolecular Screening (2014) 19:4 (538-546) DOI:10.1177/1087057113520325).” Journal of Biomolecular Screening 19, no. 10 (January 1, 2014): 1418. https://doi.org/10.1177/1087057114559509.Full Text
-
Goldstein, Michael, Frederick A. Derheimer, Jacqueline Tait-Mulder, and Michael B. Kastan. “Nucleolin mediates nucleosome disruption critical for DNA double-strand break repair.” Proc Natl Acad Sci U S A 110, no. 42 (October 15, 2013): 16874–79. https://doi.org/10.1073/pnas.1306160110.Full Text Link to Item
-
Zhang, Jiangwei, Jinhee Kim, Angela Alexander, Shengli Cai, Durga Nand Tripathi, Ruhee Dere, Andrew R. Tee, et al. “A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS.” Nat Cell Biol 15, no. 10 (October 2013): 1186–96. https://doi.org/10.1038/ncb2822.Full Text Link to Item
-
Moding, Everett J., Michael B. Kastan, and David G. Kirsch. “Strategies for optimizing the response of cancer and normal tissues to radiation.” Nat Rev Drug Discov 12, no. 7 (July 2013): 526–42. https://doi.org/10.1038/nrd4003.Full Text Link to Item
-
Zhang, J., J. Kim, A. Alexander, S. Cai, D. N. Tripathi, R. Dere, A. R. Tee, et al. “A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS.” Nature Cell Biology 15, no. 10 (2013): 1186–96. https://doi.org/10.1038/ncb2822.Full Text
-
Kastan, Michael B. “A message from the Editor-in-Chief.” Mol Cancer Res 10, no. 12 (December 2012): 1513. https://doi.org/10.1158/1541-7786.MCR-12-0644.Full Text Link to Item
-
Lim, Yiting, Mohammad Hedayati, Akil A. Merchant, Yonggang Zhang, Hsiang-Hsuan M. Yu, Michael B. Kastan, William Matsui, and Theodore L. Deweese. “Chloroquine improves survival and hematopoietic recovery after lethal low-dose-rate radiation.” Int J Radiat Oncol Biol Phys 84, no. 3 (November 1, 2012): 800–806. https://doi.org/10.1016/j.ijrobp.2012.01.026.Full Text Link to Item
-
Alexander, A., S. L. Cai, J. Kim, A. Nanez, M. Sahin, K. H. MacLean, K. Inoki, et al. “Erratum: ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS (Proceedings of the National Academy of Sciences (2010) 107 (4153-4158) DOI: 10.1073/pnas.0913860107).” Proceedings of the National Academy of Sciences of the United States of America 109, no. 21 (May 22, 2012): 8352. https://doi.org/10.1073/pnas.1206201109.Full Text
-
Chen, Jing, Kexiao Guo, and Michael B. Kastan. “Interactions of nucleolin and ribosomal protein L26 (RPL26) in translational control of human p53 mRNA.” J Biol Chem 287, no. 20 (May 11, 2012): 16467–76. https://doi.org/10.1074/jbc.M112.349274.Full Text Link to Item
-
Valentin-Vega, Yasmine A., and Michael B. Kastan. “A new role for ATM: regulating mitochondrial function and mitophagy.” Autophagy 8, no. 5 (May 1, 2012): 840–41. https://doi.org/10.4161/auto.19693.Full Text Link to Item
-
Razani, Babak, Chu Feng, Trey Coleman, Roy Emanuel, Haitao Wen, Seungmin Hwang, Jenny P. Ting, Herbert W. Virgin, Michael B. Kastan, and Clay F. Semenkovich. “Autophagy links inflammasomes to atherosclerotic progression.” Cell Metab 15, no. 4 (April 4, 2012): 534–44. https://doi.org/10.1016/j.cmet.2012.02.011.Full Text Link to Item
-
Valentin-Vega, Yasmine A., Kirsteen H. Maclean, Jacqueline Tait-Mulder, Sandra Milasta, Meredith Steeves, Frank C. Dorsey, John L. Cleveland, Douglas R. Green, and Michael B. Kastan. “Mitochondrial dysfunction in ataxia-telangiectasia.” Blood 119, no. 6 (February 9, 2012): 1490–1500. https://doi.org/10.1182/blood-2011-08-373639.Full Text Link to Item
-
DeWeese, T. L., Y. Lim, M. Hedayati, A. Merchant, Y. Zhang, H. M. Yu, M. B. Kastan, and W. Matsui. “Chloroquine Activates ATM and Improves Hematopoietic Recovery and Survival of Mice following Low Dose-rate Radiation.” International Journal of Radiation Oncology*Biology*Physics 81, no. 2 (October 2011): S191–92. https://doi.org/10.1016/j.ijrobp.2011.06.343.Full Text
-
Chen, Jing, Kexiao Guo, and Michael B. Kastan. “Abstract 3086: Interactions of nucleolin and ribosomal protein RPL26 in the translational control of human p53 mRNA.” Cellular and Molecular Biology, April 15, 2011. https://doi.org/10.1158/1538-7445.am2011-3086.Full Text
-
Chen, Jing, and Michael B. Kastan. “5'-3'-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage.” Genes Dev 24, no. 19 (October 1, 2010): 2146–56. https://doi.org/10.1101/gad.1968910.Full Text Link to Item
-
Derheimer, Frederick A., and Michael B. Kastan. “Multiple roles of ATM in monitoring and maintaining DNA integrity.” Febs Lett 584, no. 17 (September 10, 2010): 3675–81. https://doi.org/10.1016/j.febslet.2010.05.031.Full Text Link to Item
-
Leung, Wing, Geoffrey Neale, Fred Behm, Rekha Iyengar, David Finkelstein, Michael B. Kastan, and Ching-Hon Pui. “Deficient innate immunity, thymopoiesis, and gene expression response to radiation in survivors of childhood acute lymphoblastic leukemia.” Cancer Epidemiol 34, no. 3 (June 2010): 303–8. https://doi.org/10.1016/j.canep.2010.03.008.Full Text Link to Item
-
Alexander, Angela, Sheng-Li Cai, Jinhee Kim, Adrian Nanez, Mustafa Sahin, Kristeen H. MacLean, Ken Inoki, et al. “Abstract 4831: ATM signals to TSC2 in the cytoplasm to regulate mTORC1 and autophagy in response to ROS.” Cellular and Molecular Biology, April 15, 2010. https://doi.org/10.1158/1538-7445.am10-4831.Full Text
-
Zaki, Md Hasan, Kelli L. Boyd, Peter Vogel, Michael B. Kastan, Mohamed Lamkanfi, and Thirumala-Devi Kanneganti. “The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis.” Immunity 32, no. 3 (March 26, 2010): 379–91. https://doi.org/10.1016/j.immuni.2010.03.003.Full Text Link to Item
-
Alexander, Angela, Sheng-Li Cai, Jinhee Kim, Adrian Nanez, Mustafa Sahin, Kirsteen H. MacLean, Ken Inoki, et al. “ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS.” Proc Natl Acad Sci U S A 107, no. 9 (March 2, 2010): 4153–58. https://doi.org/10.1073/pnas.0913860107.Full Text Link to Item
-
Ofir-Rosenfeld, Yaara, Kristy Boggs, Dan Michael, Michael B. Kastan, and Moshe Oren. “Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.” Mol Cell 32, no. 2 (October 24, 2008): 180–89. https://doi.org/10.1016/j.molcel.2008.08.031.Full Text Link to Item
-
Rainey, Michael D., Maura E. Charlton, Robert V. Stanton, and Michael B. Kastan. “Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation.” Cancer Res 68, no. 18 (September 15, 2008): 7466–74. https://doi.org/10.1158/0008-5472.CAN-08-0763.Full Text Link to Item
-
Chandhasin, Chandtip, Razvan I. Ducu, Elijahu Berkovich, Michael B. Kastan, and Susan J. Marriott. “Human T-cell leukemia virus type 1 tax attenuates the ATM-mediated cellular DNA damage response.” J Virol 82, no. 14 (July 2008): 6952–61. https://doi.org/10.1128/JVI.02331-07.Full Text Link to Item
-
Loehberg, C. R., T. Thompson, M. B. Kastan, B. W. O’Malley, and M. W. Beckmann. “ATM and p53 are potential mediators of Chloroquine-induced resistance to mammary carcinogenesis.” Geburtshilfe Und Frauenheilkunde 68, no. 5 (May 1, 2008): 557–557.Link to Item
-
Kastan, Michael B. “DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture.” Mol Cancer Res 6, no. 4 (April 2008): 517–24. https://doi.org/10.1158/1541-7786.MCR-08-0020.Full Text Link to Item
-
Maclean, K. H., F. C. Dorsey, J. L. Cleveland, and M. B. Kastan. “Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis (Journal of Clinical Investigation (2008) 118, (79-88) DOI: 10.1172/JCI33700).” Journal of Clinical Investigation 118, no. 4 (April 1, 2008): 1584. https://doi.org/10.1172/JCI33700C1.Full Text
-
Tang, Xi, Zhou-Guang Hui, Xiao-Li Cui, Renu Garg, Michael B. Kastan, and Bo Xu. “A novel ATM-dependent pathway regulates protein phosphatase 1 in response to DNA damage.” Mol Cell Biol 28, no. 8 (April 2008): 2559–66. https://doi.org/10.1128/MCB.01711-07.Full Text Link to Item
-
Berkovich, Elijahu, Raymond J. Monnat, and Michael B. Kastan. “Assessment of protein dynamics and DNA repair following generation of DNA double-strand breaks at defined genomic sites.” Nat Protoc 3, no. 5 (2008): 915–22. https://doi.org/10.1038/nprot.2008.54.Full Text Link to Item
-
Maclean, Kirsteen H., Frank C. Dorsey, John L. Cleveland, and Michael B. Kastan. “Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis.” J Clin Invest 118, no. 1 (January 2008): 79–88. https://doi.org/10.1172/JCI33700.Full Text Link to Item
-
Loehberg, Christian R., Tiia Thompson, Michael B. Kastan, Kirsteen H. Maclean, Dean G. Edwards, Frances S. Kittrell, Daniel Medina, Orla M. Conneely, and Bert W. O’Malley. “Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.” Cancer Res 67, no. 24 (December 15, 2007): 12026–33. https://doi.org/10.1158/0008-5472.CAN-07-3058.Full Text Link to Item
-
Kastan, M. B. “A message from the editor.” Molecular Cancer Research 5, no. 11 (November 1, 2007).
-
Kastan, Michael B. “Our cells get stressed too! Implications for human disease.” Blood Cells Mol Dis 39, no. 2 (September 2007): 148–50. https://doi.org/10.1016/j.bcmd.2007.04.002.Full Text Link to Item
-
Maclean, Kirsteen H., Michael B. Kastan, and John L. Cleveland. “Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis.” Mol Cancer Res 5, no. 7 (July 2007): 705–11. https://doi.org/10.1158/1541-7786.MCR-07-0058.Full Text Link to Item
-
Berkovich, Elijahu, Raymond J. Monnat, and Michael B. Kastan. “Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair.” Nat Cell Biol 9, no. 6 (June 2007): 683–90. https://doi.org/10.1038/ncb1599.Full Text Link to Item
-
Kastan, Michael B., and Elijahu Berkovich. “p53: a two-faced cancer gene.” Nat Cell Biol 9, no. 5 (May 2007): 489–91. https://doi.org/10.1038/ncb0507-489.Full Text Link to Item
-
Kastan, Michael B. “Wild-type p53: tumors can't stand it.” Cell 128, no. 5 (March 9, 2007): 837–40. https://doi.org/10.1016/j.cell.2007.02.022.Full Text Link to Item
-
Kastan, M. B. “Editor's note.” Molecular Cancer Research 5, no. 1 (January 1, 2007).
-
Schneider, Jochen G., Brian N. Finck, Jie Ren, Kara N. Standley, Masatoshi Takagi, Kirsteen H. Maclean, Carlos Bernal-Mizrachi, Anthony J. Muslin, Michael B. Kastan, and Clay F. Semenkovich. “ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome.” Cell Metab 4, no. 5 (November 2006): 377–89. https://doi.org/10.1016/j.cmet.2006.10.002.Full Text Link to Item
-
Sandlund, John T., Michael B. Kastan, Wren Kennedy, Frederick Behm, Elaine Entrekin, Ching-Hon Pui, David T. Kalwinsky, and Susana C. Raimondi. “A subtle t(3;8) results in plausible juxtaposition of MYC and BCL6 in a child with Burkitt lymphoma/leukemia and ataxia-telangiectasia.” Cancer Genet Cytogenet 168, no. 1 (July 1, 2006): 69–72. https://doi.org/10.1016/j.cancergencyto.2005.12.013.Full Text Link to Item
-
Bekker-Jensen, Simon, Claudia Lukas, Risa Kitagawa, Fredrik Melander, Michael B. Kastan, Jiri Bartek, and Jiri Lukas. “Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks.” J Cell Biol 173, no. 2 (April 24, 2006): 195–206. https://doi.org/10.1083/jcb.200510130.Full Text Link to Item
-
Morales, Monica, Jan-Willem F. Theunissen, Carla F Bender Kim, Risa Kitagawa, Michael B. Kastan, and John H. J. Petrini. “The Rad50S allele promotes ATM-dependent DNA damage responses and suppresses ATM deficiency: implications for the Mre11 complex as a DNA damage sensor.” Genes Dev 19, no. 24 (December 15, 2005): 3043–54. https://doi.org/10.1101/gad.1373705.Full Text Link to Item
-
Takagi, M., M. J. Absalon, K. G. McLure, and M. B. Kastan. “Erratum: Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin (Cell (October 7, 2005) 123 (49-63)).” Cell 123, no. 3 (November 4, 2005): 536–37. https://doi.org/10.1016/j.cell.2005.10.012.Full Text
-
Kastan, Michael B. “Cell biology: A BID for the pathway.” Nature 437, no. 7062 (October 20, 2005): 1103. https://doi.org/10.1038/4371103a.Full Text Link to Item
-
Kastan, M. B. “DNA damage responses: Cancer and beyond.” Scientist 19, no. 19 (October 10, 2005): 24–25.
-
Takagi, Masatoshi, Michael J. Absalon, Kevin G. McLure, and Michael B. Kastan. “Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin.” Cell 123, no. 1 (October 7, 2005): 49–63. https://doi.org/10.1016/j.cell.2005.07.034.Full Text Link to Item
-
Bartkova, Jirina, Christopher J. Bakkenist, Ewa Rajpert-De Meyts, Niels E. Skakkebaek, Maxwell Sehested, Jiri Lukas, Michael B. Kastan, and Jiri Bartek. “ATM activation in normal human tissues and testicular cancer.” Cell Cycle 4, no. 6 (June 2005): 838–45. https://doi.org/10.4161/cc.4.6.1742.Full Text Link to Item
-
Kitagawa, R., and M. B. Kastan. “The ATM-dependent DNA damage signaling pathway.” Cold Spring Harb Symp Quant Biol 70 (2005): 99–109. https://doi.org/10.1101/sqb.2005.70.002.Full Text Link to Item
-
Kastan, Michael B., and Jiri Bartek. “Cell-cycle checkpoints and cancer.” Nature 432, no. 7015 (November 18, 2004): 316–23. https://doi.org/10.1038/nature03097.Full Text Link to Item
-
McLure, Kevin G., Masatoshi Takagi, and Michael B. Kastan. “NAD+ modulates p53 DNA binding specificity and function.” Mol Cell Biol 24, no. 22 (November 2004): 9958–67. https://doi.org/10.1128/MCB.24.22.9958-9967.2004.Full Text Link to Item
-
Arlt, Martin F., Bo Xu, Sandra G. Durkin, Anne M. Casper, Michael B. Kastan, and Thomas W. Glover. “BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function.” Mol Cell Biol 24, no. 15 (August 2004): 6701–9. https://doi.org/10.1128/MCB.24.15.6701-6709.2004.Full Text Link to Item
-
Karlseder, Jan, Kristina Hoke, Olga K. Mirzoeva, Christopher Bakkenist, Michael B. Kastan, John H. J. Petrini, and Titia de Lange. “The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response.” Plos Biol 2, no. 8 (August 2004): E240. https://doi.org/10.1371/journal.pbio.0020240.Full Text Link to Item
-
Bakkenist, Christopher J., and Michael B. Kastan. “Initiating cellular stress responses.” Cell 118, no. 1 (July 9, 2004): 9–17. https://doi.org/10.1016/j.cell.2004.06.023.Full Text Link to Item
-
Bakkenist, Christopher J., and Michael B. Kastan. “Phosphatases join kinases in DNA-damage response pathways.” Trends Cell Biol 14, no. 7 (July 2004): 339–41. https://doi.org/10.1016/j.tcb.2004.05.001.Full Text Link to Item
-
Kitagawa, Risa, Christopher J. Bakkenist, Peter J. McKinnon, and Michael B. Kastan. “Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway.” Genes Dev 18, no. 12 (June 15, 2004): 1423–38. https://doi.org/10.1101/gad.1200304.Full Text Link to Item
-
Surrallés, Jordi, Stephen P. Jackson, Maria Jasin, Michael B. Kastan, Stephen C. West, and Hans Joenje. “Molecular cross-talk among chromosome fragility syndromes.” Genes Dev 18, no. 12 (June 15, 2004): 1359–70. https://doi.org/10.1101/gad.1216304.Full Text Link to Item
-
Bakkenist, Christopher J., Rachid Drissi, Jing Wu, Michael B. Kastan, and Jeffrey S. Dome. “Disappearance of the telomere dysfunction-induced stress response in fully senescent cells.” Cancer Res 64, no. 11 (June 1, 2004): 3748–52. https://doi.org/10.1158/0008-5472.CAN-04-0453.Full Text Link to Item
-
Garg, Renu, Shannon Callens, Dae-Sik Lim, Christine E. Canman, Michael B. Kastan, and Bo Xu. “Chromatin association of rad17 is required for an ataxia telangiectasia and rad-related kinase-mediated S-phase checkpoint in response to low-dose ultraviolet radiation.” Mol Cancer Res 2, no. 6 (June 2004): 362–69.Link to Item
-
Horejsí, Zuzana, Jacob Falck, Christopher J. Bakkenist, Michael B. Kastan, Jiri Lukas, and Jiri Bartek. “Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation.” Oncogene 23, no. 17 (April 15, 2004): 3122–27. https://doi.org/10.1038/sj.onc.1207447.Full Text Link to Item
-
Kastan, M. B. “ATM–the first step in helping cells deal with DNA damage.” Biomedicine & Pharmacotherapy 58, no. 1 (January 2004): 72–73. https://doi.org/10.1016/s0753-3322(03)00045-3.Full Text
-
Xu, Bo, and Michael B. Kastan. “Analyzing cell cycle checkpoints after ionizing radiation.” Methods Mol Biol 281 (2004): 283–92. https://doi.org/10.1385/1-59259-811-0:283.Full Text Link to Item
-
Kastan, M. B. “Molecular Cancer Research: A Note from the Editor.” Molecular Cancer Research 1, no. 14 (December 1, 2003).
-
Cortés, M. L., C. J. Bakkenist, M. V. Di Maria, M. B. Kastan, and X. O. Breakefield. “HSV-1 amplicon vector-mediated expression of ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype.” Gene Ther 10, no. 16 (August 2003): 1321–27. https://doi.org/10.1038/sj.gt.3301996.Full Text Link to Item
-
Lee, Joo Hyeon, Bo Xu, Chang-Hun Lee, Jun-Young Ahn, Min Sup Song, Ho Lee, Christine E. Canman, Jong-Soo Lee, Michael B. Kastan, and Dae-Sik Lim. “Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage.” Mol Cancer Res 1, no. 9 (July 2003): 674–81.Link to Item
-
Bakkenist, Christopher J., and Michael B. Kastan. “DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.” Nature 421, no. 6922 (January 30, 2003): 499–506. https://doi.org/10.1038/nature01368.Full Text Link to Item
-
Kastan, Michael B., and Gerard P. Zambetti. “Parc-ing p53 in the cytoplasm.” Cell 112, no. 1 (January 10, 2003): 1–2. https://doi.org/10.1016/s0092-8674(02)01281-3.Full Text Link to Item
-
Nakanishi, Koji, Toshiyasu Taniguchi, Velvizhi Ranganathan, Helen V. New, Lisa A. Moreau, Maria Stotsky, Christopher G. Mathew, Michael B. Kastan, David T. Weaver, and Alan D. D’Andrea. “Interaction of FANCD2 and NBS1 in the DNA damage response.” Nat Cell Biol 4, no. 12 (December 2002): 913–20. https://doi.org/10.1038/ncb879.Full Text Link to Item
-
Kastan, M. B. “Welcome to molecular cancer research.” Molecular Cancer Research 1, no. 1 (November 1, 2002): 1.
-
Xu, Bo, Anne H. O’Donnell, Seong-Tae Kim, and Michael B. Kastan. “Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation.” Cancer Res 62, no. 16 (August 15, 2002): 4588–91.Link to Item
-
Taniguchi, Toshiyasu, Irene Garcia-Higuera, Bo Xu, Paul R. Andreassen, Richard C. Gregory, Seong-Tae Kim, William S. Lane, Michael B. Kastan, and Alan D. D’Andrea. “Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.” Cell 109, no. 4 (May 17, 2002): 459–72. https://doi.org/10.1016/s0092-8674(02)00747-x.Full Text Link to Item
-
Kim, Seong-Tae, Bo Xu, and Michael B. Kastan. “Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage.” Genes Dev 16, no. 5 (March 1, 2002): 560–70. https://doi.org/10.1101/gad.970602.Full Text Link to Item
-
Xu, Bo, Seong-Tae Kim, Dae-Sik Lim, and Michael B. Kastan. “Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation.” Mol Cell Biol 22, no. 4 (February 2002): 1049–59. https://doi.org/10.1128/mcb.22.4.1049-1059.2002.Full Text Link to Item
-
Taniguchi, T., I. Garcia-Higuera, W. S. Lane, S. T. Kim, B. Xu, M. B. Kastan, and A. D. D’Andrea. “Molecular interaction of the Fanconi Anemia (FA) and Ataxia Telangiectasia (AT) pathways.” Blood 98, no. 11 (November 16, 2001): 782A-782A.Link to Item
-
D’Andrea, A. D., I. Garcia-Higuera, W. S. Lane, B. Xu, M. B. Kastan, and T. Taniguchi. “Differential activation of the Fanconi Anemia protein, FANCD2, by monoubiquitination and phosphorylation.” Molecular Biology of the Cell 12 (November 1, 2001): 5A-6A.Link to Item
-
Thomas, C., G. Ely, C. D. James, R. Jenkins, M. Kastan, A. Jedlicka, P. Burger, and R. Wharen. “Glioblastoma-related gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells.” Acta Neuropathol 101, no. 6 (June 2001): 605–15. https://doi.org/10.1007/s004010000332.Full Text Link to Item
-
Maya, R., M. Balass, S. T. Kim, D. Shkedy, J. F. Leal, O. Shifman, M. Moas, et al. “ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.” Genes Dev 15, no. 9 (May 1, 2001): 1067–77. https://doi.org/10.1101/gad.886901.Full Text Link to Item
-
Xu, B., B. Kim St, and M. B. Kastan. “Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation.” Mol Cell Biol 21, no. 10 (May 2001): 3445–50. https://doi.org/10.1128/MCB.21.10.3445-3450.2001.Full Text Link to Item
-
Kastan, M. B. “Cell cycle. Checking two steps.” Nature 410, no. 6830 (April 12, 2001): 766–67. https://doi.org/10.1038/35071218.Full Text Link to Item
-
Koumenis, C., R. Alarcon, E. Hammond, P. Sutphin, W. Hoffman, M. Murphy, J. Derr, et al. “Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.” Mol Cell Biol 21, no. 4 (February 2001): 1297–1310. https://doi.org/10.1128/MCB.21.4.1297-1310.2001.Full Text Link to Item
-
Kastan, M. B., D. S. Lim, S. T. Kim, and D. Yang. “ATM--a key determinant of multiple cellular responses to irradiation.” Acta Oncol 40, no. 6 (2001): 686–88. https://doi.org/10.1080/02841860152619089.Full Text Link to Item
-
Shiloh, Y., and M. B. Kastan. “ATM: genome stability, neuronal development, and cancer cross paths.” Adv Cancer Res 83 (2001): 209–54. https://doi.org/10.1016/s0065-230x(01)83007-4.Full Text Link to Item
-
Kastan, M. B., and D. S. Lim. “The many substrates and functions of ATM.” Nat Rev Mol Cell Biol 1, no. 3 (December 2000): 179–86. https://doi.org/10.1038/35043058.Full Text Link to Item
-
Yang, D. Q., and M. B. Kastan. “Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1.” Nat Cell Biol 2, no. 12 (December 2000): 893–98. https://doi.org/10.1038/35046542.Full Text Link to Item
-
Cleveland, J. L., and M. B. Kastan. “Cancer. A radical approach to treatment.” Nature 407, no. 6802 (September 21, 2000): 309–11. https://doi.org/10.1038/35030277.Full Text Link to Item
-
Lim, D. S., S. T. Kim, B. Xu, R. S. Maser, J. Lin, J. H. Petrini, and M. B. Kastan. “ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.” Nature 404, no. 6778 (April 6, 2000): 613–17. https://doi.org/10.1038/35007091.Full Text Link to Item
-
Pandita, T. K., H. B. Lieberman, D. S. Lim, S. Dhar, W. Zheng, Y. Taya, and M. B. Kastan. “Ionizing radiation activates the ATM kinase throughout the cell cycle.” Oncogene 19, no. 11 (March 9, 2000): 1386–91. https://doi.org/10.1038/sj.onc.1203444.Full Text Link to Item
-
Kastan, M. B., D. S. Lim, S. T. Kim, B. Xu, and C. Canman. “Multiple signaling pathways involving ATM.” Cold Spring Harb Symp Quant Biol 65 (2000): 521–26. https://doi.org/10.1101/sqb.2000.65.521.Full Text Link to Item
-
Ziv, Y., S. Banin, D. S. Lim, C. E. Canman, M. B. Kastan, and Y. Shiloh. “Expression and assay of recombinant ATM.” Methods Mol Biol 99 (2000): 99–108. https://doi.org/10.1385/1-59259-054-3:99.Full Text Link to Item
-
Kim, S. T., D. S. Lim, C. E. Canman, and M. B. Kastan. “Substrate specificities and identification of putative substrates of ATM kinase family members.” J Biol Chem 274, no. 53 (December 31, 1999): 37538–43. https://doi.org/10.1074/jbc.274.53.37538.Full Text Link to Item
-
DiGiuseppe, J. A., L. J. Weng, K. H. Yu, S. Fu, M. B. Kastan, D. Samid, and S. D. Gore. “Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: structure-function analysis.” Leukemia 13, no. 8 (August 1999): 1243–53. https://doi.org/10.1038/sj.leu.2401471.Full Text Link to Item
-
Kastan, M. B. “Molecular determinants of sensitivity to antitumor agents.” Biochim Biophys Acta 1424, no. 1 (July 29, 1999): R37–42. https://doi.org/10.1016/s0304-419x(99)00020-7.Full Text Link to Item
-
Kirsch, D. G., A. Doseff, B. N. Chau, D. S. Lim, N. C. de Souza-Pinto, R. Hansford, M. B. Kastan, Y. A. Lazebnik, and J. M. Hardwick. “Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c.” J Biol Chem 274, no. 30 (July 23, 1999): 21155–61. https://doi.org/10.1074/jbc.274.30.21155.Full Text Link to Item
-
DiGiuseppe, J. A., M. B. Kastan, L. J. Weng, and S. D. Gore. “Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1.” In Vivo 13, no. 1 (January 1999): 1–6.Link to Item
-
Westphal, C. H., K. P. Hoyes, C. E. Canman, X. Huang, M. B. Kastan, J. H. Hendry, and P. Leder. “Loss of atm radiosensitizes multiple p53 null tissues.” Cancer Res 58, no. 24 (December 15, 1998): 5637–39.Link to Item
-
Rhodes, N., T. D’Souza, C. D. Foster, Y. Ziv, D. G. Kirsch, Y. Shiloh, M. B. Kastan, P. H. Reinhart, and T. M. Gilmer. “Defective potassium currents in ataxia telangiectasia fibroblasts.” Genes Dev 12, no. 23 (December 1, 1998): 3686–92. https://doi.org/10.1101/gad.12.23.3686.Full Text Link to Item
-
Leung, W., A. R. Chen, R. C. Klann, T. J. Moss, J. M. Davis, S. J. Noga, K. J. Cohen, et al. “Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma.” Bone Marrow Transplant 22, no. 10 (November 1998): 971–79. https://doi.org/10.1038/sj.bmt.1701471.Full Text Link to Item
-
Giaccia, A. J., and M. B. Kastan. “The complexity of p53 modulation: emerging patterns from divergent signals.” Genes Dev 12, no. 19 (October 1, 1998): 2973–83. https://doi.org/10.1101/gad.12.19.2973.Full Text Link to Item
-
Canman, C. E., D. S. Lim, K. A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M. B. Kastan, and J. D. Siliciano. “Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.” Science 281, no. 5383 (September 11, 1998): 1677–79. https://doi.org/10.1126/science.281.5383.1677.Full Text Link to Item
-
Kirsch, D. G., and M. B. Kastan. “Tumor-suppressor p53: implications for tumor development and prognosis.” J Clin Oncol 16, no. 9 (September 1998): 3158–68. https://doi.org/10.1200/JCO.1998.16.9.3158.Full Text Link to Item
-
Lim, D. S., D. G. Kirsch, C. E. Canman, J. H. Ahn, Y. Ziv, L. S. Newman, R. B. Darnell, Y. Shiloh, and M. B. Kastan. “ATM binds to beta-adaptin in cytoplasmic vesicles.” Proc Natl Acad Sci U S A 95, no. 17 (August 18, 1998): 10146–51. https://doi.org/10.1073/pnas.95.17.10146.Full Text Link to Item
-
Comer, K. A., P. A. Dennis, L. Armstrong, J. J. Catino, M. B. Kastan, and C. C. Kumar. “Human smooth muscle alpha-actin gene is a transcriptional target of the p53 tumor suppressor protein.” Oncogene 16, no. 10 (March 12, 1998): 1299–1308. https://doi.org/10.1038/sj.onc.1201645.Full Text Link to Item
-
Canman, C. E., and M. B. Kastan. “Small contribution of G1 checkpoint control manipulation to modulation of p53-mediated apoptosis.” Oncogene 16, no. 8 (February 26, 1998): 957–66. https://doi.org/10.1038/sj.onc.1201612.Full Text Link to Item
-
Clem, R. J., E. H. Cheng, C. L. Karp, D. G. Kirsch, K. Ueno, A. Takahashi, M. B. Kastan, et al. “Modulation of cell death by Bcl-XL through caspase interaction.” Proc Natl Acad Sci U S A 95, no. 2 (January 20, 1998): 554–59. https://doi.org/10.1073/pnas.95.2.554.Full Text Link to Item
-
Dennis, P. A., and M. B. Kastan. “Cellular survival pathways and resistance to cancer therapy.” Drug Resist Updat 1, no. 5 (1998): 301–9. https://doi.org/10.1016/s1368-7646(98)80046-0.Full Text Link to Item
-
Siliciano, J. D., C. E. Canman, Y. Taya, K. Sakaguchi, E. Appella, and M. B. Kastan. “DNA damage induces phosphorylation of the amino terminus of p53.” Genes Dev 11, no. 24 (December 15, 1997): 3471–81. https://doi.org/10.1101/gad.11.24.3471.Full Text Link to Item
-
Cheng, E. H., D. G. Kirsch, R. J. Clem, R. Ravi, M. B. Kastan, A. Bedi, K. Ueno, and J. M. Hardwick. “Conversion of Bcl-2 to a Bax-like death effector by caspases.” Science 278, no. 5345 (December 12, 1997): 1966–68. https://doi.org/10.1126/science.278.5345.1966.Full Text Link to Item
-
Kastan, M. B., S. E. Morgan, J. Siliciano, D. Kirsch, P. Dennis, and C. E. Canman. “Cell cycle and cell death after DNA damaye.” Faseb Journal 11, no. 9 (December 1, 1997).
-
Kastan, M. B. “To oxidize or not to oxidize?” Nature Medicine 3, no. 11 (November 1997): 1192–93. https://doi.org/10.1038/nm1197-1192.Full Text
-
Smilenov, L. B., S. E. Morgan, W. Mellado, S. G. Sawant, M. B. Kastan, and T. K. Pandita. “Influence of ATM function on telomere metabolism.” Oncogene 15, no. 22 (November 1997): 2659–65. https://doi.org/10.1038/sj.onc.1201449.Full Text
-
Agani, F., D. G. Kirsch, S. L. Friedman, M. B. Kastan, and G. L. Semenza. “p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene.” Cancer Res 57, no. 20 (October 15, 1997): 4474–77.Link to Item
-
Metcalfe, S. M., C. E. Canman, J. Milner, R. E. Morris, S. Goldman, and M. B. Kastan. “Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cells.” Oncogene 15, no. 14 (October 2, 1997): 1635–42. https://doi.org/10.1038/sj.onc.1201341.Full Text Link to Item
-
Kastan, M. “On the TRAIL from p53 to apoptosis?” Nature Genetics 17, no. 2 (October 1997): 130–31. https://doi.org/10.1038/ng1097-130.Full Text
-
Chabner, B. A., M. B. Kastan, and B. A. Teicher. “Untitled.” Clinical Cancer Research 3, no. 9 (September 1, 1997): 1455–1455.Link to Item
-
Morgan, S. E., and M. B. Kastan. “Dissociation of radiation-induced phosphorylation of replication protein A from the S-phase checkpoint.” Cancer Res 57, no. 16 (August 15, 1997): 3386–89.Link to Item
-
Kastan, M. B., S. E. Morgan, J. Siliciano, D. Kirsch, P. Dennis, and C. E. Canman. “Cell cycle and cell death after DNA damage.” Faseb Journal 11, no. 9 (July 31, 1997): A879–A879.Link to Item
-
Baskaran, R., L. D. Wood, L. L. Whitaker, C. E. Canman, S. E. Morgan, Y. Xu, C. Barlow, et al. “Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation.” Nature 387, no. 6632 (May 29, 1997): 516–19. https://doi.org/10.1038/387516a0.Full Text Link to Item
-
DiGiuseppe, J. A., and M. B. Kastan. “Apoptosis in haematological malignancies.” J Clin Pathol 50, no. 5 (May 1997): 361–64. https://doi.org/10.1136/jcp.50.5.361.Full Text Link to Item
-
Morgan, S. E., C. Lovly, T. K. Pandita, Y. Shiloh, and M. B. Kastan. “Fragments of ATM which have dominant-negative or complementing activity.” Mol Cell Biol 17, no. 4 (April 1997): 2020–29. https://doi.org/10.1128/mcb.17.4.2020.Full Text Link to Item
-
Canman, C. E., and M. B. Kastan. “Role of p53 in apoptosis.” Adv Pharmacol 41 (1997): 429–60. https://doi.org/10.1016/s1054-3589(08)61068-6.Full Text Link to Item
-
Kastan, M. B. “Genetic instability and tumorigenesis: introduction.” Curr Top Microbiol Immunol 221 (1997): 1–4. https://doi.org/10.1007/978-3-642-60505-5_1.Full Text Link to Item
-
Kastan, M. B. “Checkpoint controls and cancer. Introduction.” Cancer Surv 29 (1997): 1–6.Link to Item
-
Morgan, S. E., and M. B. Kastan. “p53 and ATM: cell cycle, cell death, and cancer.” Adv Cancer Res 71 (1997): 1–25. https://doi.org/10.1016/s0065-230x(08)60095-0.Full Text Link to Item
-
Canman, C. E., and M. B. Kastan. “Signal transduction. Three paths to stress relief.” Nature 384, no. 6606 (November 21, 1996): 213–14. https://doi.org/10.1038/384213a0.Full Text Link to Item
-
DiGiuseppe, J. A., S. D. Gore, L. J. Weng, and M. B. Kastan. “Growth factor modulation of p21(WAF1/CIP1) in primary acute myeloid leukemias.” Blood 88, no. 10 (November 15, 1996): 331–331.Link to Item
-
Pandita, T. K., E. J. Hall, T. K. Hei, M. A. Piatyszek, W. E. Wright, C. Q. Piao, R. K. Pandita, et al. “Chromosome end-to-end associations and telomerase activity during cancer progression in human cells after treatment with alpha-particles simulating radon progeny.” Oncogene 13, no. 7 (October 3, 1996): 1423–30.Link to Item
-
Gerson, S. L., W. Phillips, M. Kastan, L. L. Dumenco, and C. Donovan. “Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive O6-alkylguanine-DNA alkyltransferase and are sensitive to O6-benzylguanine plus BCNU.” Blood 88, no. 5 (September 1, 1996): 1649–55.Link to Item
-
Chen, C. Y., I. Hall, T. J. Lansing, T. M. Gilmer, T. D. Tlsty, and M. B. Kastan. “Separate pathways for p53 induction by ionizing radiation and N-(phosphonoacetyl)-L-aspartate.” Cancer Res 56, no. 16 (August 15, 1996): 3659–62.Link to Item
-
Inaba, T., T. Inukai, T. Yoshihara, H. Seyschab, R. A. Ashmun, C. E. Canman, S. J. Laken, M. B. Kastan, and A. T. Look. “Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor.” Nature 382, no. 6591 (August 8, 1996): 541–44. https://doi.org/10.1038/382541a0.Full Text Link to Item
-
Kastan, M. B. “Signalling to p53: where does it all start?” Bioessays 18, no. 8 (August 1996): 617–19. https://doi.org/10.1002/bies.950180804.Full Text Link to Item
-
Liebermann, D. A. “Molecular biology of normal development, malignancy and its suppression.” Oncogene 12, no. 10 (May 16, 1996): 2247–50.Link to Item
-
Goldman, S. C., C. Y. Chen, T. J. Lansing, T. M. Gilmer, and M. B. Kastan. “The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization.” Am J Pathol 148, no. 5 (May 1996): 1381–85.Link to Item
-
Inaba, T., T. Inukai, T. Yoshihara, H. Seyschab, R. A. Ashmun, C. E. Canman, S. J. Laken, M. B. Kastan, and A. T. Look. “The oncogenic E2A-HLF fusion protein protects leukemic B-precursor cells from apoptosis.” Blood 86, no. 10 (November 15, 1995): 1297–1297.Link to Item
-
Yao, S., A. J. Akhtar, G. C. Bedi, D. Sidransky, M. B. Kastan, J. P. Barber, K. A. McKenna, et al. “DNA damage induced apoptosis by p53-mediated activation of p34(cdc2) kinase.” Blood 86, no. 10 (November 15, 1995): 1714–1714.Link to Item
-
Kastan, M. “Ataxia-telangiectasia--broad implications for a rare disorder.” N Engl J Med 333, no. 10 (September 7, 1995): 662–63. https://doi.org/10.1056/NEJM199509073331014.Full Text Link to Item
-
Kilpatrick, K. E., F. Carrier, M. L. Smith, C. Y. Chen, A. J. Lee, D. W. Rusnak, M. B. Kastan, A. J. Fornace, B. R. Champion, and T. M. Gilmer. “The production and characterization of murine monoclonal antibodies to human Gadd45 raised against a recombinant protein.” Hybridoma 14, no. 4 (August 1995): 355–59. https://doi.org/10.1089/hyb.1995.14.355.Full Text Link to Item
-
Zhan, Q., W. Eldeiry, I. Bae, I. Alamo, M. Kastan, B. Vogelstein, and A. Fornace. “Similarity of the DNA-damage responsiveness and growth-suppressive properties of waf1/cip1 and gadd45.” Int J Oncol 6, no. 5 (May 1995): 937–46. https://doi.org/10.3892/ijo.6.5.937.Full Text Link to Item
-
Canman, C. E., T. M. Gilmer, S. B. Coutts, and M. B. Kastan. “Growth factor modulation of p53-mediated growth arrest versus apoptosis.” Genes Dev 9, no. 5 (March 1, 1995): 600–611. https://doi.org/10.1101/gad.9.5.600.Full Text Link to Item
-
Kastan, M. B., C. E. Canman, and C. J. Leonard. “P53, cell cycle control and apoptosis: implications for cancer.” Cancer Metastasis Rev 14, no. 1 (March 1995): 3–15. https://doi.org/10.1007/BF00690207.Full Text Link to Item
-
Canman, C. E., and M. B. Kastan. “Induction of apoptosis by tumor suppressor genes and oncogenes.” Semin Cancer Biol 6, no. 1 (February 1995): 17–25. https://doi.org/10.1006/scbi.1995.0003.Full Text Link to Item
-
Leonard, C. J., C. E. Canman, and M. B. Kastan. “The role of p53 in cell-cycle control and apoptosis: implications for cancer.” Important Adv Oncol, 1995, 33–42.Link to Item
-
Carrier, F., M. L. Smith, I. Bae, K. E. Kilpatrick, T. J. Lansing, C. Y. Chen, M. Engelstein, S. H. Friend, W. D. Henner, and T. M. Gilmer. “Characterization of human Gadd45, a p53-regulated protein.” J Biol Chem 269, no. 51 (December 23, 1994): 32672–77.Link to Item
-
Hartwell, L. H., and M. B. Kastan. “Cell cycle control and cancer.” Science 266, no. 5192 (December 16, 1994): 1821–28. https://doi.org/10.1126/science.7997877.Full Text Link to Item
-
Smith, M. L., I. T. Chen, Q. Zhan, I. Bae, C. Y. Chen, T. M. Gilmer, M. B. Kastan, P. M. O’Connor, and A. J. Fornace. “Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen.” Science 266, no. 5189 (November 25, 1994): 1376–80. https://doi.org/10.1126/science.7973727.Full Text Link to Item
-
Canman, C. E., A. C. Wolff, C. Y. Chen, A. J. Fornace, and M. B. Kastan. “The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia.” Cancer Res 54, no. 19 (October 1, 1994): 5054–58.Link to Item
-
Slebos, R. J., M. H. Lee, B. S. Plunkett, T. D. Kessis, B. O. Williams, T. Jacks, L. Hedrick, M. B. Kastan, and K. R. Cho. “p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.” Proc Natl Acad Sci U S A 91, no. 12 (June 7, 1994): 5320–24. https://doi.org/10.1073/pnas.91.12.5320.Full Text Link to Item
-
Zhan, Q., I. Bae, M. B. Kastan, and A. J. Fornace. “The p53-dependent gamma-ray response of GADD45.” Cancer Res 54, no. 10 (May 15, 1994): 2755–60.Link to Item
-
Chen, C. Y., J. D. Oliner, Q. Zhan, A. J. Fornace, B. Vogelstein, and M. B. Kastan. “Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.” Proc Natl Acad Sci U S A 91, no. 7 (March 29, 1994): 2684–88. https://doi.org/10.1073/pnas.91.7.2684.Full Text Link to Item
-
Deiry, W. S. el-, J. W. Harper, P. M. O’Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, and Y. Wang. “WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.” Cancer Res 54, no. 5 (March 1, 1994): 1169–74.Link to Item
-
Nelson, W. G., and M. B. Kastan. “DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.” Mol Cell Biol 14, no. 3 (March 1994): 1815–23. https://doi.org/10.1128/mcb.14.3.1815.Full Text Link to Item
-
KASTAN, M. B., W. G. NELSON, C. Y. CHEN, and W. B. SLICHENMYER. “P53 AND OTHER MOLECULAR CONTROLS OF THE RESPONSE TO DNA-DAMAGE.” Journal of Cellular Biochemistry, February 13, 1994, 164–164.Link to Item
-
KASTAN, M. B., W. G. NELSON, C. Y. CHEN, and W. B. SLICHENMYER. “P53 AND OTHER MOLECULAR CONTROLS OF THE RESPONSE TO DNA-DAMAGE.” Journal of Cellular Biochemistry, February 13, 1994, 209–209.Link to Item
-
Canman, C. E., C. Y. Chen, M. H. Lee, and M. B. Kastan. “DNA damage responses: p53 induction, cell cycle perturbations, and apoptosis.” Cold Spring Harb Symp Quant Biol 59 (1994): 277–86. https://doi.org/10.1101/sqb.1994.059.01.032.Full Text Link to Item
-
Wechsler, D. S., M. B. Kastan, and B. A. Fivush. “Resolution of nephrocalcinosis associated with tumor lysis syndrome.” Pediatr Hematol Oncol 11, no. 1 (January 1994): 115–18. https://doi.org/10.3109/08880019409141909.Full Text Link to Item
-
Kastan, M. B., and S. J. Kuerbitz. “Control of G1 arrest after DNA damage.” Environ Health Perspect 101 Suppl 5 (December 1993): 55–58. https://doi.org/10.1289/ehp.93101s555.Full Text Link to Item
-
Moran, N. M., M. B. Kastan, M. B. DeCabrio, E. Mihich, and E. Kufe. “Discussion of Dr. Kastan's presentation.” Advances in Experimental Medicine and Biology 339 (December 1, 1993): 295–96.
-
Kastan, M. B. “Experimental models of human carcinogenesis.” Nat Genet 5, no. 3 (November 1993): 207–8. https://doi.org/10.1038/ng1193-207.Full Text Link to Item
-
KASTAN, M. B. “HOT PAPERS - ONCOLOGY - PARTICIPATION OF P53 PROTEIN IN THE CELLULAR-RESPONSE TO DNA-DAMAGE BY KASTAN,M.B., ONYEKWERE,O., SIDRANSKY,D., ET-AL.” Scientist 7, no. 18 (September 20, 1993): 16–16.Link to Item
-
Slichenmyer, W. J., W. G. Nelson, R. J. Slebos, and M. B. Kastan. “Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage.” Cancer Res 53, no. 18 (September 15, 1993): 4164–68.Link to Item
-
Craig, R. W., H. L. Buchan, C. I. Civin, and M. B. Kastan. “Altered cytoplasmic/nuclear distribution of the c-myc protein in differentiating ML-1 human myeloid leukemia cells.” Cell Growth Differ 4, no. 5 (May 1993): 349–57.Link to Item
-
Kessis, T. D., R. J. Slebos, W. G. Nelson, M. B. Kastan, B. S. Plunkett, S. M. Han, A. T. Lorincz, L. Hedrick, and K. R. Cho. “Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.” Proc Natl Acad Sci U S A 90, no. 9 (May 1, 1993): 3988–92. https://doi.org/10.1073/pnas.90.9.3988.Full Text Link to Item
-
ZHAN, Q. M., M. B. KASTAN, F. CARRIER, M. C. HOLLANDER, and A. J. FORNACE. “IDENTIFICATION OF A P53-REGULATED GENE INVOLVED IN A CELL-CYCLE CHECKPOINT ACTIVATED BY DNA DAMAGE.” Journal of Cellular Biochemistry, January 9, 1993, 141–141.Link to Item
-
Kastan, M. B. “P53: a determinant of the cell cycle response to DNA damage.” Adv Exp Med Biol 339 (1993): 291–93. https://doi.org/10.1007/978-1-4615-2488-5_28.Full Text Link to Item
-
Resar, L. M., P. C. Phillips, M. B. Kastan, B. G. Leventhal, P. W. Bowman, and C. I. Civin. “Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B-cell type.” Cancer 71, no. 1 (January 1, 1993): 117–23. https://doi.org/10.1002/1097-0142(19930101)71:1<117::aid-cncr2820710119>3.0.co;2-k.Full Text Link to Item
-
Kastan, M. B., Q. Zhan, W. S. el-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace. “A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.” Cell 71, no. 4 (November 13, 1992): 587–97. https://doi.org/10.1016/0092-8674(92)90593-2.Full Text Link to Item
-
Kuerbitz, S. J., B. S. Plunkett, W. V. Walsh, and M. B. Kastan. “Wild-type p53 is a cell cycle checkpoint determinant following irradiation.” Proc Natl Acad Sci U S A 89, no. 16 (August 15, 1992): 7491–95. https://doi.org/10.1073/pnas.89.16.7491.Full Text Link to Item
-
Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. “Participation of p53 protein in the cellular response to DNA damage.” Cancer Res 51, no. 23 Pt 1 (December 1, 1991): 6304–11.Link to Item
-
Kastan, M. B., A. I. Radin, S. J. Kuerbitz, O. Onyekwere, C. A. Wolkow, C. I. Civin, K. D. Stone, T. Woo, Y. Ravindranath, and R. W. Craig. “Levels of p53 protein increase with maturation in human hematopoietic cells.” Cancer Res 51, no. 16 (August 15, 1991): 4279–86.Link to Item
-
Kaufmann, S. H., S. J. McLaughlin, M. B. Kastan, L. F. Liu, J. E. Karp, and P. J. Burke. “Topoisomerase II levels during granulocytic maturation in vitro and in vivo.” Cancer Res 51, no. 13 (July 1, 1991): 3534–43.Link to Item
-
Gore, S. D., M. B. Kastan, and C. I. Civin. “Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells.” Blood 77, no. 8 (April 15, 1991): 1681–90.Link to Item
-
KASTAN, M. B. “Levels of p53 protein increase with maturation in human hematopoietic cells.” Cancer Res. 51 (1991): 4279–86.
-
Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. “Participation of p53 Protein in the Cellular Response to DNA Damage.” Cancer Research 51 (January 1, 1991): 6304–11.
-
Gore, S. D., M. B. Kastan, S. N. Goodman, and C. I. Civin. “Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry.” J Immunol Methods 132, no. 2 (September 14, 1990): 275–86. https://doi.org/10.1016/0022-1759(90)90039-x.Full Text Link to Item
-
Gore, S., M. Kastan, and C. Civin. “Flow cytometric identification of intracellular antigens: detection of minimal residual leukemia.” Bone Marrow Transplant 6 Suppl 1 (July 1990): 39–41.Link to Item
-
Kastan, M. B., E. Schlaffer, J. E. Russo, O. M. Colvin, C. I. Civin, and J. Hilton. “Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells.” Blood 75, no. 10 (May 15, 1990): 1947–50.Link to Item
-
Kastan, M. B., and C. I. Civin. “Acute leukemia in children.” Curr Opin Oncol 2, no. 1 (February 1990): 34–40. https://doi.org/10.1097/00001622-199002000-00006.Full Text Link to Item
-
Kastan, M. B., K. D. Stone, and C. I. Civin. “Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells.” Blood 74, no. 5 (October 1989): 1517–24.Link to Item
-
Kastan, M. B., D. J. Slamon, and C. I. Civin. “Expression of protooncogene c-myb in normal human hematopoietic cells.” Blood 73, no. 6 (May 1, 1989): 1444–51.Link to Item
-
Kastan, M. B., B. A. Zehnbauer, B. G. Leventhal, B. J. Corden, and G. J. Dover. “Philadelphia-chromosome positive essential thrombocythemia. Two cases in children.” Am J Pediatr Hematol Oncol 11, no. 4 (1989): 433–36.Link to Item
-
Kastan, M. B., L. C. Strauss, and C. I. Civin. “The role of hematopoietic growth factors and oncogenes in leukemogenesis.” Am J Pediatr Hematol Oncol 11, no. 3 (1989): 249–67.Link to Item
-
KASTAN, M. B., D. J. SLAMON, and C. L. CIVIN. “PROTO-ONCOGENE C-MYB IS EXPRESSED IN NORMAL HUMAN HEMATOPOIETIC PROGENITOR CELLS.” Experimental Hematology 16, no. 6 (July 1, 1988): 507–507.Link to Item
-
Barr, F. G., M. B. Kastan, and M. W. Lieberman. “Distribution of 5-methyldeoxycytidine in products of staphylococcal nuclease digestion of nuclei and purified DNA.” Biochemistry 24, no. 6 (March 12, 1985): 1424–28. https://doi.org/10.1021/bi00327a021.Full Text Link to Item
-
Barr, F. G., M. B. Kastan, and M. W. Lieberman. “Distribution of 5-methyldeoxycytidine in products of staphylococcal nuclease digestion of nuclei and purified DNA.” Federation Proceedings 43, no. 7 (January 1, 1984).
-
LIEBERMAN, M. W., M. B. KASTAN, and F. G. BARR. “METHYLATION OF DEOXYCYTIDINE INCORPORATED BY REPAIR SYNTHESIS FOLLOWING DAMAGE WITH ULTRAVIOLET-RADIATION AND CHEMICAL CARCINOGENS.” Proceedings of the American Association for Cancer Research 24, no. MAR (January 1, 1983): 335–335.Link to Item
-
Kastan, M. B., B. J. Gowans, and M. W. Lieberman. “Methylation of deoxycytidine incorporated by excision-repair synthesis of DNA.” Cell 30, no. 2 (September 1982): 509–16. https://doi.org/10.1016/0092-8674(82)90248-3.Full Text Link to Item
-
Smerdon, M. J., M. B. Kastan, and M. W. Lieberman. “Distribution of repair-incorporated nucleotides and nucleosome rearrangement in the chromatin of normal and xeroderma pigmentosum human fibroblasts.” Biochemistry 18, no. 17 (August 21, 1979): 3732–39. https://doi.org/10.1021/bi00584a014.Full Text Link to Item
-
-
Book Sections
-
Ford, J. M., and M. B. Kastan. “DNA Damage Response Pathways and Cancer.” In Abeloff’s Clinical Oncology: Fifth Edition, 142-153.e4, 2013. https://doi.org/10.1016/B978-1-4557-2865-7.00010-2.Full Text
-
McLure, K. G., and M. B. Kastan. “20 years of DNA damage signaling to p53.” In 25 Years of P53 Research, 53–71, 2005. https://doi.org/10.1007/978-1-4020-2922-6_3.Full Text
-
-
Conference Papers
-
Kastan, Michael B., Peter Scarbrough, Jing Chen, Adam Brown, John Crutchley, and Donald Fleenor. “Abstract IA17: Non-canonical aspects of ATM and p53 signaling pathways.” In Dna Damage Signaling. American Association for Cancer Research, 2017. https://doi.org/10.1158/1557-3125.dnarepair16-ia17.Full Text
-
Musselwhite, Laura W., Kristin Schroeder, Manisha Bhattacharya, Sky Breeden Vanderburg, Nestory Andrew Masalu, Mammen Chandy, Edmundo Mauad, et al. “Duke University Global Cancer Program: A multidisciplinary approach to partnerships in global cancer care.” In Journal of Clinical Oncology, 33:e17584–e17584. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.e17584.Full Text
-
Kastan, Michael B. “Abstract IA11: New insights into DNA double-strand break responses.” In Oral Presentations. American Association for Cancer Research, 2014. https://doi.org/10.1158/1538-7445.cansusc14-ia11.Full Text
-
Bharatham, Kavitha, Praveen Kumar Suryadevara, Kexiao Guo, Jaeki Min, Michael B. Kastan, R Kiplin Guy, and Anang Shelat. “Optimizing ATM inhibitor activity and specificity using pharmacophore-based docking.” In Abstracts of Papers of the American Chemical Society, Vol. 243. AMER CHEMICAL SOC, 2012.Link to Item
-
DeWire, M. D., AS Pai Pananandiker, D. E. Ellison, P. J. McKinnon, M. B. Kastan, and A. Gajjar. “RADIATION THERAPY AND ADJUVANT CHEMOTHERAPY IN A PATIENT WITH A HIGH GRADE GLIOMA AND UNDERLYING ATAXIA TELANGIECTASIA.” In Neuro Oncology, 12:II87–II87. OXFORD UNIV PRESS INC, 2010.Link to Item
-
Kastan, M. B., R. Kitagawa, and C. J. Bakkenist. “DNA damage response pathways in cancer causation and treatment.” In Breast Cancer Research, Vol. 7. Springer Science and Business Media LLC, 2005. https://doi.org/10.1186/bcr1049.Full Text
-
Loehberg, C. R., T. Thompson, M. B. Kastan, O. M. Conneely, D. Medina, and B. W. O’Malley. “Activation of ATM and p53 in mammary gland epithelial cells as a possible breast cancer prevention model.” In Breast Cancer Research and Treatment, 94:S173–S173. SPRINGER, 2005.Link to Item
-
Schneider, J. G., J. Ren, C. Feng, T. Coleman, M. B. Kastan, A. J. Muslin, and C. F. Semenkovich. “ATM haploinsufficiency produces vascular insulin resistance, impaired glucose tolerance, hypertension, and accelerated atherosclerosis in apoE null mice.” In Arteriosclerosis Thrombosis and Vascular Biology, 24:E5–E5. LIPPINCOTT WILLIAMS & WILKINS, 2004.Link to Item
-
Arlt, M. F., S. G. Durkin, A. M. Casper, M. B. Kastan, and T. W. Glover. “BRCA1 deficient cells have increased fragile site expression that is complemented by wild type BRCA1.” In American Journal of Human Genetics, 71:181–181. CELL PRESS, 2002.Link to Item
-
Kastan, M. B., D. S. Lim, S. T. Kim, and C. E. Canman. “Roles of TP53 and ATM in radiation responses.” In Radiation Research, Vol 2, Congress Proceedings, edited by M. Moriaty, M. Edington, C. Mothersill, J. F. Ward, C. Seymour, and R. J. M. Fry, 413–15. ALLEN PRESS INC, 2000.Link to Item
-
KASTAN, M. B. “MOLECULAR CONTROLS OF CELL-CYCLE PROGRESSION FOLLOWING DNA-DAMAGE - ROLES OF P(53) AND ATAXIA-TELANGIECTASIA GENE-PRODUCTS.” In Apoptosis, edited by E. Mihich and R. T. Schimke, 5:117–35. PLENUM PRESS DIV PLENUM PUBLISHING CORP, 1994.Link to Item
-
-
- Teaching & Mentoring
-
Recent Courses
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.
